Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020
April 24 2020 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company
will host a conference call and live audio webcast on Thursday, May
7, 2020 at 8:30 a.m. ET to discuss financial results for the first
quarter ended March 31, 2020.
The call will be led by John F. Crowley,
Chairman and Chief Executive Officer. He will be joined on the call
by additional members of the Amicus senior leadership team.
Interested participants and investors may access the conference
call by dialing 877-303-5859 (U.S./Canada) or 678-224-7784
(international), conference ID: 1287896.
A live audio webcast and related presentation
materials can also be accessed via the Investors section of the
Amicus Therapeutics corporate website at ir.amicusrx.com. Web
participants are encouraged to register on the website 15 minutes
prior to the start of the call.
A replay of the call will be available for seven
days beginning at 11:30 a.m. ET. Access numbers for this replay are
855-859-2056 (U.S./Canada) and 404-537-3406 (international);
conference ID: 1287896.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow on Twitter and
LinkedIn.
CONTACT:
Amicus TherapeuticsAndrew FaughnanDirector,
Investor Relationsafaughnan@amicusrx.com (609) 662-3809
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024